trending Market Intelligence /marketintelligence/en/news-insights/trending/Ea9XNK5LIlgxwnx8etGvaA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

S&P lowers issue-level rating on Endo International's senior secured debt

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

S&P lowers issue-level rating on Endo International's senior secured debt

S&P Global Ratings lowered the issue-level rating on Endo International PLC senior secured debt to B+ from BB- following plans by the company's unit to refinance $1 billion of senior notes.

The rating agency said Endo's long-term issuer credit rating of B and the stable outlook on the company remain unchanged.

S&P Global Ratings also revised its recovery rating to 2 from 1, which indicates that an 80% recovery is expected in the event of a payment default.

The downgrade to the issue-level rating on Endo's senior secured debt represents the incremental weakening of recovery prospects because secured debt will now represent a larger proportion of the company's capital structure, according to the rating agency.

S&P Global Ratings, however, views the transaction, including the proposed extension of the credit facility as positive for the Dublin-based company's liquidity profile because it extends overall maturity schedule and lowers the amount due in 2022.

The rating agency added that the opioid litigation is a significant risk for the company, though the U.S. generic market is stabilizing and Endo's top branded products still have a significant runway.

This S&P Global Market Intelligence news article may contain information about credit ratings issued by S&P Global Ratings. Descriptions in this news article were not prepared by S&P Global Ratings.